Avacta is pleased to announce that it has raised gross proceeds of £3.25 million from long term, high net worth investors introduced by Zeus Capital Limited. #AVCT.

Avacta announces that at the Annual General Meeting held this morning, all resolutions were duly passed by shareholders (with the exception of Resolution 3 which was not put to the meeting). #AVCT.

Avacta Provides Q2 2025 Business Update Outlining Progress Against Strategic Objectives. #AVCT.

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development. #AVCT.

Appointment of Zeus Capital as Joint Broker to Avacta Group plc. #AVCT.

RT @trinity_delta: New IP & Tempus AI collaboration cld support @avacta's product & tech-based business dev. #preCISION pipeline progress….

RT @coughlin582: Delighted to be at #BiotechWeekBoston connecting with industry and highlighting the great progress preCISION continues to….

Avacta announces a new partial response observed in a patient with salivary gland cancer in the dose expansion phase of the FAP-Dox (AVA6000) Phase 1b trial. #AVCT.

RT @trinity_delta: Key 25/26 data from @avacta's lead #preCISION progs: 1) #AVA6000 (FAP-Dox) initial #SGC data late-25 & #TNBC data H126;….

Please note the Notice of AGM can be found on page 128 of the Annual Report and Accounts, a link to which is here: #AVCT.

The Company had intended to hold the AGM on June 30, however due to some logistical considerations and investor feedback on the prior date, the Company will convene the AGM on Wed, July 2, at 9:00am at the offices of Peel Hunt LLP, 7th Floor, 100 Liverpool Street, London EC2M 2AT.

Avacta announces that the Annual Report and Accounts for the year ended December 31, 2024 and the Notice of AGM are available on the Company's website. #AVCT.

RT @InvestorMeetCo: Couldn't make today's live presentation with AVACTA GROUP PLC? #AVCT @avacta. No problem! Catch up here: .

Preliminary Results for the Year Ended December 31, 2024 #AVCT.

Update on timing of preliminary results announcement. #AVCT.

Avacta announces the appointments of David Bryant and Richard Hughes as Non-Executive Directors with immediate effect

Read the new @Citeline article, 'The pre|CISION Approach: How Avacta Is Making Toxic Cancer Drugs Safe And More Effective', here: #AVCT.

Avacta will announce its audited preliminary results for year ended December 31, 2024 on May 29, 2025. #AVCT.

We are delighted to have been shortlisted for the Best Technology Award at the European Mediscience Awards 2025. #EMA25 #AVCT

Find out more here: